We now seek comments on two new lipid pathways:
- Primary prevention lipid pathway
- Secondary prevention statin intolerance pathway. This pathway is intended to be used alongside the secondary prevention medication eligibility pathway which is already published and available here.
This consultations will run for six weeks and close at 5pm on Wednesday 12th November. To take part, visit the consultations page.